Health Care: Drugs

Rigel Pharmaceuticals Inc (RIGL: NASDAQ)

$2.59 n/a | n/a%
08/22/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 7.15M 2.25M 4.75M 125.00M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 7.15M 2.25M 4.75M 125.00M
Selling, General, and Administrative Expenses 19.61M 22.85M 21.77M 25.29M
Research & Development 75.33M 78.78M 69.35M 64.39M
Operating Income before D & A (EBITDA) -87.79M -99.38M -86.37M 35.32M
Depreciation & Amortization 2.59M 2.43M 1.96M 1.32M
Interest Income 442.00K 537.00K 420.00K 303.00K
Other Income - Net 0.00 0.00 0.00 2.36M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -91.62M -101.27M -87.90M 36.66M
Interest Expense 0.00 0.00 25.00K 91.00K
Pre-Tax Income -91.62M -101.27M -87.93M 36.57M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -89.03M -98.84M -85.97M 37.89M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -89.03M -98.84M -85.97M 37.89M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -89.03M -98.84M -85.97M 37.89M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-87.35M -98.84M -85.97M 37.89M
Preferred Dividends
Net Income Available To Common -89.03M -98.84M -85.97M 37.89M
Basic EPS from Continuing Ops. -1.02 -1.32 -1.36 0.73
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.02 -1.32 -1.36 0.73
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.02 -1.32 -1.36 0.73
Basic Normalized Net Income/Share -1.00 -1.32 -1.36 0.73
EPS fr Continuing Ops. -1.02 -1.32 -1.36 0.72
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.02 -1.32 -1.36 0.72
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.02 -1.32 -1.36 0.72
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.00 -1.32 -1.36 0.72
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with RIGL

Latest RIGL Headlines from TheStreet

More Financial News for RIGL

Press Releases for RIGL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter